Literature DB >> 22157706

Lipoprotein subfractions and particle size in end-stage renal disease.

Peter A McCullough, Fawaz Al-Ejel, Robert C Maynard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22157706      PMCID： PMC3255361          DOI： 10.2215/CJN.10281011

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  14 in total

Review 1.  Renal dysfunction and acceleration of coronary disease.

Authors:  M W Yerkey; S J Kernis; B A Franklin; K R Sandberg; P A McCullough
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

Review 2.  Amplification of atherosclerotic calcification and Mönckeberg's sclerosis: a spectrum of the same disease process.

Authors:  Peter A McCullough; Kavitha M Chinnaiyan; Varun Agrawal; Ewa Danielewicz; George S Abela
Journal:  Adv Chronic Kidney Dis       Date:  2008-10       Impact factor: 3.620

Review 3.  Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity.

Authors:  Peter O Kwiterovich
Journal:  Am J Cardiol       Date:  2002-10-17       Impact factor: 2.778

4.  Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.

Authors:  Helen M Colhoun; James D Otvos; Mike B Rubens; M R Taskinen; S Richard Underwood; John H Fuller
Journal:  Diabetes       Date:  2002-06       Impact factor: 9.461

5.  Relationship between obesity and concentration and composition of low-density lipoprotein subfractions in normoinsulinemic men.

Authors:  M Halle; A Berg; I Frey; D König; J Keul; M W Baumstark
Journal:  Metabolism       Date:  1995-11       Impact factor: 8.694

6.  LDL particle size and number compared with LDL cholesterol and risk categorization in end-stage renal disease patients.

Authors:  Rodney G Bowden; Ronald L Wilson; A Alexander Beaujean
Journal:  J Nephrol       Date:  2011 Nov-Dec       Impact factor: 3.902

Review 7.  Lipids in chronic kidney disease.

Authors:  David Lewis; Richard Haynes; Martin J Landray
Journal:  J Ren Care       Date:  2010-05

8.  Comparison of lipid measures and risk stratification among end-stage renal disease patients.

Authors:  Rodney G Bowden; Stuart Hebert; Ronald Wilson; Mindy Gentile; Beth A Lanning
Journal:  J Nephrol       Date:  2007 Mar-Apr       Impact factor: 3.902

9.  Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality.

Authors:  Peter A McCullough; Suying Li; Claudine T Jurkovitz; Leslie Stevens; Alan J Collins; Shu-Cheng Chen; Keith C Norris; Samy McFarlane; Bruce Johnson; Michael G Shlipak; Chamberlain I Obialo; Wendy W Brown; Joseph Vassalotti; Joseph Vassaloti; Adam T Whaley-Connell; Robert M Brenner; George L Bakris
Journal:  Am Heart J       Date:  2008-06-04       Impact factor: 4.749

10.  Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.

Authors:  Karim El Harchaoui; Wim A van der Steeg; Erik S G Stroes; Jan Albert Kuivenhoven; James D Otvos; Nicholas J Wareham; Barbara A Hutten; John J P Kastelein; Kay-Tee Khaw; S Matthijs Boekholdt
Journal:  J Am Coll Cardiol       Date:  2007-01-22       Impact factor: 24.094
View more
  1 in total

1.  Association of high-density lipoprotein cholesterol with the estimated glomerular filtration rate in a community-based population.

Authors:  Fan Wang; Jin Zheng; Ping Ye; Leiming Luo; Yongyi Bai; Ruyi Xu; Li Sheng; Tiehui Xiao; Hongmei Wu
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.